Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer

被引:2
|
作者
Huang, Yibao [1 ]
Zhu, Qingqing [1 ]
Xue, Liru [1 ]
Zhu, Xiaoran [1 ]
Chen, Yingying [1 ]
Wu, Mingfu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Natl Clin Res Ctr Obstetr & Gynecol Dis, Key Lab Canc Invas & Metastasis, Tongji Hosp,Tongji Med Coll,Dept Gynecol,Minist E, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
locally advanced cervical cancer; neoadjuvant chemotherapy; machine learning analysis; predictive model; pathology response; INFLAMMATION MARKERS; RADICAL HYSTERECTOMY; CURATIVE RESECTION; SURGERY; VALIDATION; FIBRINOGEN; EFFICACY;
D O I
10.3389/fonc.2022.817250
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The clinical benefit of neoadjuvant chemotherapy (NACT) before concurrent chemoradiotherapy (CCRT) vs. adjuvant chemotherapy after CCRT is debated. Non-response to platinum-based NACT is a major contributor to poor prognosis, but there is currently no reliable method for predicting the response to NACT (rNACT) in patients with locally advanced cervical cancer (LACC). In this study we developed a machine learning (ML)-assisted model to accurately predict rNACT. We retrospectively analyzed data on 636 patients diagnosed with stage IB2 to IIA2 cervical cancer at our hospital between January 1, 2010 and December 1, 2020. Five ML-assisted models were developed from candidate clinical features using 2-step estimation methods. Receiver operating characteristic curve (ROC), clinical impact curve, and decision curve analyses were performed to evaluate the robustness and clinical applicability of each model. A total of 30 candidate variables were ultimately included in the rNACT prediction model. The areas under the ROC curve of models constructed using the random forest classifier (RFC), support vector machine, eXtreme gradient boosting, artificial neural network, and decision tree ranged from 0.682 to 0.847. The RFC model had the highest predictive accuracy, which was achieved by incorporating inflammatory factors such as platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, neutrophil-to-albumin ratio, and lymphocyte-to-monocyte ratio. These results demonstrate that the ML-based prediction model developed using the RFC can be used to identify LACC patients who are likely to respond to rNACT, which can guide treatment selection and improve clinical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] A Machine Learning Tool to Predict the Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer
    Arezzo, Francesca
    La Forgia, Daniele
    Venerito, Vincenzo
    Moschetta, Marco
    Tagliafico, Alberto Stefano
    Lombardi, Claudio
    Loizzi, Vera
    Cicinelli, Ettore
    Cormio, Gennaro
    [J]. APPLIED SCIENCES-BASEL, 2021, 11 (02): : 1 - 10
  • [2] Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer
    Fisher, Timothy B.
    Saini, Geetanjali
    Rekha, T. S.
    Krishnamurthy, Jayashree
    Bhattarai, Shristi
    Callagy, Grace
    Webber, Mark
    Janssen, Emiel A. M.
    Kong, Jun
    Aneja, Ritu
    [J]. BREAST CANCER RESEARCH, 2024, 26 (01)
  • [3] Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer
    Timothy B. Fisher
    Geetanjali Saini
    T. S. Rekha
    Jayashree Krishnamurthy
    Shristi Bhattarai
    Grace Callagy
    Mark Webber
    Emiel A. M. Janssen
    Jun Kong
    Ritu Aneja
    [J]. Breast Cancer Research, 26
  • [4] Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study
    Sun, Caixia
    Tian, Xin
    Liu, Zhenyu
    Li, Weili
    Li, Pengfei
    Chen, Jiaming
    Zhang, Weifeng
    Fang, Ziyu
    Du, Peiyan
    Duan, Hui
    Liu, Ping
    Wang, Lihui
    Chen, Chunlin
    Tian, Jie
    [J]. EBIOMEDICINE, 2019, 46 : 160 - 169
  • [5] Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
    Chiappa, Valentina
    Bogani, Giorgio
    Interlenghi, Matteo
    Antisari, Giulia Vittori
    Salvatore, Christian
    Zanchi, Lucia
    Ludovisi, Manuela
    Maggiore, Umberto Leone Roberti
    Calareso, Giuseppina
    Haeusler, Edward
    Raspagliesi, Francesco
    Castiglioni, Isabella
    [J]. DIAGNOSTICS, 2023, 13 (19)
  • [6] Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
    Colombo, N.
    Peiretti, M.
    Parma, G.
    Mancari, R.
    Garbi, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S67 - S67
  • [7] Neoadjuvant chemotherapy for locally advanced cervical cancer
    Iwata, Takashi
    Miyauchi, Azumi
    Suga, Yukako
    Nishio, Hiroshi
    Nakamura, Masaru
    Ohno, Akiko
    Hirao, Nobumaru
    Morisada, Tohru
    Tanaka, Kyoko
    Ueyama, Hiroki
    Watari, Hidemichi
    Aoki, Daisuke
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (02) : 235 - 240
  • [8] NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER
    Mousavi, A.
    Mousavi, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [9] NEOADJUVANT CHEMOTHERAPY OF LOCALLY ADVANCED CERVICAL CANCER
    Kuznetsova, O.
    Rybin, A.
    Dubynina, V.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [10] Neoadjuvant chemotherapy for locally advanced cervical cancer
    Timotheadou, E
    Gore, ME
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (17) : 2419 - 2421